November 08, 2022
A Delaware federal judge has cleared pharmaceutical maker Apotex in rival Horizon's patent suit over a generic version of anti-inflammatory drug Pennsaid, ruling that Apotex's agreement with a different licensor grants the generic maker implied rights to the continuation patent at issue.